Thematic Poster
Clinical aspects of lung cancer
Chairs
D. Baldwin
Nottingham (Nottinghamshire)
(United Kingdom)
Endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) reduces time for diagnosis of lung cancer if used as the initial diagnostic test of choice
M. Tufail(Leicester (Leicestershire), United Kingdom)
COI
1
Diagnostic yeild of ultrasound guided transthoracic fine needle aspiration cytology (ttfnac) in diagnosis of intrathoracic lesions
K. Venugopal(Alappuzha (Kerala), India)
COI
2
The proportion of EGFR+ NSCLC patients never treated with TKI – A single institution Croatian experience
S. Pleština(Zagreb, Croatia)
COI
3
Pneumothoraces in CT guided lung biopsies – Are we too cautious?
A. Low(Long Ashton, United Kingdom)
COI
4
Physiological predictors of mortality in high-risk patients undergoing surgery for lung cancer
H. Law(Manchester (Greater Manchester), United Kingdom)
COI
5
Normal lymph node size at Endobronchial ultrasound guided Transbronchial needle aspiration correlates to benign cytopathological diagnosis but does not rule out malignancy
U. Bodtger(Naestved, Denmark)
COI
6
Preoperative FDG uptake on PET/CT predicts disease recurrence and survival in early stage non-small cell lung cancer (NSCLC)
E. Denneny(London, United Kingdom)
COI
7
Evaluation of spirometry test as monitoring tool in lung cancer patients
D. Aggarwal(Chandigarh (Uttar Pradesh), India)
COI
8
Three-year spirometric evolution after lobectomy in lung cancer patients with or without COPD previous surgery
W. Giron Matute(Madrid, Spain)
COI
9
Profile of non-neoplasic mediastinal lymph nodes (NNLN) during the study of lung cáncer (LC)
L. Padron Fraysse(Mairena del Aljarafe, Spain)
COI
10
An audit of prognostic significance of histological subtype in surgically resected adenocarcinomas
S. MacRae(Preston, United Kingdom)
COI
11
Prognostic factors to survival in patients with lung cancer and superior vena cava syndrome: A retrospective analysis
L. Fernandes(Oeiras, Portugal)
COI
12
Lung cancer: Independent death predictor in cancer patients admitted after emergency visit
J. Gorham(Bruxelles, Belgium)
COI
13
The efficacy and safety of CT-guided percutaneous hookwire localization in VATS for pulmonary nodules
W. van Geffen(Leeuwarden, Netherlands)
COI
14
Procalcitonin serum levels in patients with stage IV non-small cell lung cancer in first line of chemotherapy
C. Andrejak(Amiens, France)
COI
15
Pulmonary function during lung cancer therapy: A retrospective analysis of patients treated with monotherapy or multimodal treatments
A. Tufman(München, Germany)
COI
16
Lung cancer tissue diagnosis in poor lung function: Addressing the ongoing percutaneous lung biopsy FEV1 paradox using Heimlich valve
R. Abdullah(London, United Kingdom)
COI
17
Non-small cell lung cancer (NSCLC) pathological sub-typing in convex and radial endobronchial ultrasound (EBUS) specimens compared to surgical resection
T. Edwards(Brisbane (QLD), Australia)
COI
18
Endoscopic ultrasound guided liver biopsy in the hands of a chest physician
M. Fally(Copenhagen, Denmark)
COI
19
How safe and justified is invasive diagnostic of lung tumours in elderly patients?
K. Adamic(Golnik, Slovenia)
COI
20
. . .
